FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Betaine Hydrochloride (Cystadane) for Oral Solution
Status: Currently in Shortage
»Date first posted: 01/09/2018
»Therapeutic Categories: Gastroenterology

Recordati Rare Diseases (New 01/09/2018)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
180 grams/bottle (NDC 52276-400-01) Available Recordati Rare Diseases in conjunction with FDA has initiated temporary importation Betaine Hydrochloride (Cystadane) for oral solution into the U.S. market to address drug shortages.

Dear Health Care Provider Letter


Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English